These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6199509)

  • 21. Comparison of the antibodies elicited by the individual structural polypeptides of foot-and mouth disease and polio viruses.
    Meloen RH; Rowlands DJ; Brown F
    J Gen Virol; 1979 Dec; 45(3):761-3. PubMed ID: 94352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3.
    Minor PD; Evans DM; Ferguson M; Schild GC; Westrop G; Almond JW
    J Gen Virol; 1985 May; 66 ( Pt 5)():1159-65. PubMed ID: 2582084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production of monoclonal and monospecific antibodies against non-capsid proteins of poliovirus.
    Pasamontes L; Egger D; Bienz K
    J Gen Virol; 1986 Nov; 67 ( Pt 11)():2415-22. PubMed ID: 2431100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of monoclonal antibodies for the identification of the antigenic site for poliovirus neutralization.
    Minor PD; Schild GC; Evans D; Ferguson M; Almond J
    Dev Biol Stand; 1984; 57():171-5. PubMed ID: 6084608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A poliovirus type 1 neutralization epitope is located within amino acid residues 93 to 104 of viral capsid polypeptide VP1.
    Wychowski C; van der Werf S; Siffert O; Crainic R; Bruneau P; Girard M
    EMBO J; 1983; 2(11):2019-24. PubMed ID: 6196195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for common, intertypic antigenic determinants on poliovirus capsid polypeptides.
    Blondel B; Crainic R; Akacem O; Bruneau P; Girard M; Horodniceanu F
    Virology; 1982 Dec; 123(2):461-3. PubMed ID: 6184881
    [No Abstract]   [Full Text] [Related]  

  • 27. Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site.
    Blondel B; Crainic R; Fichot O; Dufraisse G; Candrea A; Diamond D; Girard M; Horaud F
    J Virol; 1986 Jan; 57(1):81-90. PubMed ID: 2416957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intertypic cross-neutralization of polioviruses by human monoclonal antibodies.
    Uhlig H; Dernick R
    Virology; 1988 Mar; 163(1):214-7. PubMed ID: 2831657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bivalent attachment of antibody onto poliovirus leads to conformational alteration and neutralization.
    Emini EA; Ostapchuk P; Wimmer E
    J Virol; 1983 Nov; 48(2):547-50. PubMed ID: 6194315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stabilization by host cell components and Mg2+ of the neutralization epitopes of poliovirus.
    Rombaut B; Vrijsen R; Boeyé A
    J Gen Virol; 1985 Feb; 66 ( Pt 2)():303-7. PubMed ID: 2578552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critical role of an eight-amino acid sequence of VP1 in neutralization of poliovirus type 3.
    Evans DM; Minor PD; Schild GS; Almond JW
    Nature; 1983 Aug 4-10; 304(5925):459-62. PubMed ID: 6192344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibodies reveal in blocking reactions the antigenicity and antibody response of poliovirus.
    Uhlig H; Rutter G; Dernick R
    Dev Biol Stand; 1984; 57():187-91. PubMed ID: 6084610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hybridoma antibodies to poliovirus N and H antigen.
    Brioen P; Sijens RJ; Vrijsen R; Rombaut B; Thomas AA; Jackers A; Boeyé A
    Arch Virol; 1982; 74(4):325-30. PubMed ID: 6187316
    [No Abstract]   [Full Text] [Related]  

  • 34. Mapping of linear epitopes on the capsid proteins of swine vesicular disease virus using monoclonal antibodies.
    Borrego B; García-Ranea JA; Douglas A; Brocchi E
    J Gen Virol; 2002 Jun; 83(Pt 6):1387-1395. PubMed ID: 12029154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigens to viral capsid and non-capsid proteins are present in brain tissues and antibodies in sera of Theiler's virus-infected mice.
    Cameron K; Zhang X; Seal B; Rodriguez M; Njenga MK
    J Virol Methods; 2001 Jan; 91(1):11-9. PubMed ID: 11164481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigenic sites of poliovirus type 3 eliciting IgA monoclonal antibodies in orally immunized mice.
    Buttinelli G; Ruggeri FM; Marturano J; Novello F; Donati V; Fiore L
    Virology; 2001 Mar; 281(2):265-71. PubMed ID: 11277698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigenic sites on type 2 poliovirus.
    Patel V; Ferguson M; Minor PD
    Virology; 1993 Jan; 192(1):361-4. PubMed ID: 7685967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pH-dependent antigenic conversion of empty capsids of poliovirus studied with the aid of monoclonal antibodies to N and H antigen.
    Rombaut B; Vrijsen R; Brioen P; Boeyé A
    Virology; 1982 Oct; 122(1):215-8. PubMed ID: 6291235
    [No Abstract]   [Full Text] [Related]  

  • 39. A competition immunoprecipitation assay of unlabeled poliovirus antigens.
    Rombaut B; Jore J; Boeyé A
    J Virol Methods; 1994 Jun; 48(1):73-9. PubMed ID: 7962262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Four independent antigenic determinants on the capsid polypeptides of aphthovirus.
    Haresnape JM; McCahon D
    J Gen Virol; 1983 Nov; 64 (Pt 11)():2345-55. PubMed ID: 6196438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.